The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
313.90
+0.10 (0.03%)
At close: Jun 16, 2026
DSE:IBNSINA Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 15, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 9,807 | 9,189 | 7,805 | 8,954 | 9,270 | 7,708 | |
Market Cap Growth | 6.99% | 17.73% | -12.84% | -3.40% | 20.27% | 10.08% |
Enterprise Value | 13,095 | 10,667 | 8,919 | 9,692 | 9,892 | 8,398 |
Last Close Price | 313.90 | 287.80 | 239.44 | 268.97 | 272.99 | 223.17 |
PE Ratio | 12.44 | 14.51 | 11.64 | 14.79 | 15.30 | 15.76 |
PS Ratio | 0.73 | 0.77 | 0.69 | 0.98 | 1.09 | 1.05 |
PB Ratio | 2.20 | 2.30 | 2.21 | 2.93 | 3.53 | 3.59 |
P/TBV Ratio | 2.26 | 2.34 | 2.23 | 2.96 | 3.56 | 3.59 |
P/FCF Ratio | - | - | - | 18.93 | 173.59 | 24.89 |
P/OCF Ratio | 11.83 | 12.70 | 20.02 | 9.97 | 22.15 | 13.96 |
EV/Sales Ratio | 0.97 | 0.90 | 0.78 | 1.06 | 1.17 | 1.14 |
EV/EBITDA Ratio | 10.08 | 9.81 | 8.16 | 6.22 | 9.69 | 9.11 |
EV/EBIT Ratio | 11.89 | 11.82 | 9.75 | 11.82 | 12.05 | 11.46 |
EV/FCF Ratio | - | - | - | 20.49 | 185.25 | 27.12 |
Debt / Equity Ratio | 0.80 | 0.52 | 0.53 | 0.32 | 0.41 | 0.40 |
Debt / EBITDA Ratio | 2.75 | 1.86 | 1.69 | 0.62 | 1.02 | 0.91 |
Debt / FCF Ratio | - | - | - | 2.09 | 20.02 | 2.80 |
Net Debt / Equity Ratio | 0.72 | 0.43 | 0.38 | 0.24 | 0.27 | 0.27 |
Net Debt / EBITDA Ratio | 2.50 | 1.58 | 1.22 | 0.47 | 0.68 | 0.63 |
Net Debt / FCF Ratio | -1.84 | -6.66 | -2.39 | 1.53 | 13.03 | 1.87 |
Asset Turnover | 1.57 | 1.69 | 1.98 | 1.96 | 2.08 | 2.03 |
Inventory Turnover | 4.45 | 4.18 | 4.99 | 4.86 | 5.49 | 6.00 |
Quick Ratio | 0.16 | 0.22 | 0.32 | 0.23 | 0.35 | 0.27 |
Current Ratio | 0.78 | 1.15 | 1.13 | 1.26 | 1.46 | 1.26 |
Return on Equity (ROE) | 18.99% | 16.82% | 20.38% | 21.33% | 25.37% | 24.91% |
Return on Assets (ROA) | 8.01% | 8.02% | 9.93% | 11.00% | 12.59% | 12.58% |
Return on Invested Capital (ROIC) | 11.83% | 12.81% | 15.78% | 17.23% | 20.43% | 19.27% |
Return on Capital Employed (ROCE) | 18.80% | 17.80% | 21.80% | 23.10% | 25.80% | 27.20% |
Earnings Yield | 8.04% | 6.89% | 8.59% | 6.76% | 6.54% | 6.35% |
FCF Yield | -17.59% | -2.81% | -7.13% | 5.28% | 0.58% | 4.02% |
Dividend Yield | 2.04% | 2.22% | 2.63% | 2.23% | 2.20% | 2.11% |
Payout Ratio | 25.36% | 30.62% | 26.83% | 29.49% | 29.28% | 26.89% |
Total Shareholder Return | 2.04% | 2.22% | 2.63% | 2.23% | 2.20% | 2.11% |